Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis, Journal of Vascular Surgery, vol.62, issue.4, p.1091, 2015. ,
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary, Journal of Oncology Practice, vol.10, issue.6, pp.e421-e424, 2014. ,
, Guideline Summary: Use of Epoetin and Darbepoetin in Patients With Cancer?2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update, Journal of Oncology Practice, vol.4, issue.1, pp.48-52, 2008.
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials, Expert Opinion on Drug Safety, vol.19, issue.6, pp.707-733, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02997564
A brief history of opiates, opioid peptides, and opioid receptors., Proceedings of the National Academy of Sciences, vol.90, issue.12, pp.5391-5393, 1993. ,
, Meselson-Radding Model Of Recombination (1975 Proc Natl Acad Sci USA 72:358), Proc Natl Acad Sci USA, vol.90, pp.5391-5393
Opioids and the treatment of chronic pain: Controversies, current status, and future directions., Experimental and Clinical Psychopharmacology, vol.16, issue.5, pp.405-416, 2008. ,
Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice, Journal of Opioid Management, vol.4, issue.5, p.271, 2018. ,
Opioids for chronic non-cancer pain, BJA Education, vol.18, issue.11, pp.337-341, 2018. ,
Analgesic Effect of the Synthetic Cannabinoid CT-3 on Chronic Neuropathic Pain, JAMA, vol.290, issue.13, p.1757, 2003. ,
A Qualitative Systematic Review of the Role of N-Methyl-d-Aspartate Receptor Antagonists in Preventive Analgesia, Anesthesia & Analgesia, vol.5, pp.1385-1400, 2004. ,
Perioperative Epidural or Intravenous Ketamine Does Not Improve the Effectiveness of Thoracic Epidural Analgesia for Acute and Chronic Pain After Thoracotomy, The Clinical Journal of Pain, vol.30, issue.6, pp.490-500, 2014. ,
Perioperative ketamine does not prevent chronic pain after thoracotomy, European Journal of Pain, vol.13, issue.5, pp.497-505, 2009. ,
S(+)-ketamine for control of 12 perioperative pain and prevention of post thoracotomy pain syndrome: a 13 randomized, double-blind study, Minerva Anestesiol, vol.78, pp.757-766, 2012. ,
Topical 2% Amitriptyline and 1% Ketamine in Neuropathic Pain Syndromes, Anesthesiology, vol.103, issue.1, pp.140-146, 2005. ,
Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients, PLOS ONE, vol.11, issue.4, p.e0152741, 2016. ,
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus?associated sensory neuropathy, Journal of NeuroVirology, vol.12, issue.4, pp.328-331, 2006. ,
A Placebo-Controlled Randomized Crossover Trial of the N-Methyl-d-Aspartic Acid Receptor Antagonist, Memantine, in Patients with Chronic Phantom Limb Pain, Anesthesia & Analgesia, vol.98, pp.408-413, 2004. ,
Memantine (a N-methyl-d-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. (Danish Pain Research Center, University of Aarhus, Aarhus, Denmark) Anesth Analg 2000;91:960-966., Pain Practice, vol.1, issue.2, pp.204-205, 2001. ,
Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes, Pain, vol.82, issue.2, pp.111-125, 1999. ,
Ketamine for chronic pain: risks and benefits, British Journal of Clinical Pharmacology, vol.77, issue.2, pp.357-367, 2014. ,
Ketamine: Current applications in anesthesia, pain, and critical care, Anesthesia: Essays and Researches, vol.8, issue.3, p.283, 2014. ,
A systematic review and meta?analysis of memantine for the prevention or treatment of chronic pain, European Journal of Pain, vol.2, pp.1234-1250, 2019. ,
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch, British Journal of Anaesthesia, vol.107, issue.4, pp.490-502, 2011. ,
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch, British Journal of Anaesthesia, vol.107, issue.4, pp.490-502, 2011. ,
Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1, British Journal of Pharmacology, vol.128, issue.2, pp.428-434, 1999. ,
, Book Reviews, Australian Journal of Psychology, vol.51, issue.3, pp.211-212, 1999.
Topical capsaicin (low concentration) for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, p.10111, 2012. ,
Topical capsaicin (high concentration) for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, vol.1, p.7393, 2017. ,
0.025% Capsaicin Gel for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Crossover, Placebo-Controlled Trial, Pain Practice, vol.13, issue.6, pp.497-503, 2012. ,
0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial, Journal of Clinical Neuroscience, vol.62, pp.174-179, 2019. ,
Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study, The Journal of Pain, vol.18, issue.1, pp.42-53, 2017. ,
Zwischen Preußen und Russland ? das 18. Jahrhundert, Geschichte Polens, vol.18, pp.42-53, 2017. ,
Efficacy and Safety of 0.625% and 1.25% 22 Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and 23 Semi-Double Blind Controlled Study, Pain Physician, vol.20, pp.27-35, 2017. ,
Liposomal topical capsaicin in post-herpetic neuralgia: a safety pilot study, Arquivos de Neuro-Psiquiatria, vol.73, issue.3, pp.237-240, 2015. ,
A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton?s neuroma, PAIN, vol.157, issue.6, pp.1297-1304, 2016. ,
Topical Capsaicin in the Management of HIV-Associated Peripheral Neuropathy, Journal of Pain and Symptom Management, vol.19, issue.1, pp.45-52, 2000. ,
Capsaicin, Nociception and Pain, Molecules, vol.21, issue.6, p.797, 2016. ,
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use, Pain and Therapy, vol.5, issue.2, pp.149-169, 2016. ,
Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development, European Journal of Pain, vol.18, issue.4, pp.465-481, 2013. ,
Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development, European Journal of Pain, vol.18, issue.4, pp.465-481, 2013. ,
Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin, European Journal of Pain, vol.15, issue.9, pp.907-912, 2011. ,
Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews, Cochrane Database of Systematic Reviews, vol.8, p.8609, 2017. ,
Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial, Current Medical Research and Opinion, vol.35, issue.5, pp.757-766, 2019. ,
Efficacy and Safety of Lidocaine Infusion Treatment for Neuropathic Pain, Regional Anesthesia and Pain Medicine, vol.43, issue.4, pp.415-424, 2018. ,
Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype, PAIN, vol.156, issue.11, pp.2234-2244, 2015. ,
Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype, PAIN, vol.156, issue.11, pp.2234-2244, 2015. ,
Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia, Clinical Drug Investigation, vol.29, issue.6, pp.393-408, 2009. ,
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB), Supportive Care in Cancer, vol.17, issue.4, pp.451-460, 2009. ,
41: Topical amitriptyline versus lidocaine in the treatment of neuropathic pain, Regional Anesthesia and Pain Medicine, vol.32, issue.5, pp.12-12, 2007. ,
A Randomized Controlled Trial of 5% Lidocaine Gel for HIV-Associated Distal Symmetric Polyneuropathy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.37, issue.5, pp.1584-1586, 2004. ,
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study, Pain, vol.106, issue.1, pp.151-158, 2003. ,
The Lidocaine Patch 5% Effectively Treats All Neuropathic Pain Qualities: Results of a Randomized, Double-Blind, Vehicle-Controlled, 3-Week Efficacy Study With Use of the Neuropathic Pain Scale, The Clinical Journal of Pain, vol.18, issue.5, pp.297-301, 2002. ,
Botulinum Toxin for the Treatment of Neuropathic Pain, Toxins, vol.9, issue.9, p.260, 2017. ,
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain, Annals of Neurology, vol.64, issue.3, pp.274-283, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00292356
Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial, The Lancet Neurology, vol.15, issue.6, pp.555-565, 2016. ,
The effects of intradermal botulinum toxin 10 type a injections on pain symptoms of patients with diabetic neuropathy, J Res, p.11 ,
, New Facts About Parasites, Scientific American, vol.111, issue.6, pp.106-106, 1914.
OnabotulinumtoxinA Improves Tactile and Mechanical Pain Perception in Painful Diabetic Polyneuropathy, The Clinical Journal of Pain, vol.29, issue.4, pp.305-310, 2013. ,
Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial, Neurology, vol.72, issue.17, pp.1473-1478, 2009. ,
The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta?analysis of randomized controlled trials, Brain and Behavior, vol.9, issue.10, p.1409, 2019. ,
Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis, The Journal of Pain, vol.21, issue.3-4, pp.281-293, 2020. ,
Efficacy and safety of botulinum toxin type A for upper 24 limb spasticity after stroke or traumatic brain injury: a systematic review with 25 meta-analysis and trial sequential analysis, Eur J Phys Rehabil Med, vol.26, pp.256-267, 2017. ,
The effect of onabotulinumtoxinA according to site of injection in patients with overactive bladder: a systematic review and meta-analysis, World Journal of Urology, vol.36, issue.2, pp.305-317, 2017. ,
The IASP classification of chronic pain for 31 ICD-11: chronic neuropathic pain, Pain, vol.160, pp.53-59, 2019. ,
Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review, Frontiers in Pharmacology, vol.8, p.86, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01682157
Oxycodone for neuropathic pain and fibromyalgia in adults, 2014. ,
Analysis of the Cochrane Review: Incentives for Smoking Cessation. Cochrane Database Syst Rev. 2015;5:CD004307., Acta Médica Portuguesa, vol.29, issue.1, p.12, 2016. ,
Fentanyl for neuropathic pain in adults, 2015. ,
Análise da Revisão Cochrane: Cromoscopia Versus Colonoscopia Convencional na Deteção de Pólipos ColoRetais. Cochrane Database Syst Rev. 2016;4:CD006439, Acta Médica Portuguesa, vol.29, issue.10, p.583, 2016. ,
Morphine for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, vol.5, p.11669, 2017. ,
Tramadol for neuropathic pain in adults, Cochrane Database of Systematic Reviews, 2017. ,
Análise da Revisão Cochrane: Alta Hospitalar Precoce para Hospitalização Domiciliária. Cochrane Database Syst Rev. 2017;6:CD000356., Acta Médica Portuguesa, vol.30, issue.12, p.835, 2017. ,
, World Drug Report 2012, United Nations Office on Drugs and Crime. World drug report, 2012.
, Figure 6?source data 1. Pairwise information on imports of live swine from specific countries is available from 1996?2012., vol.9, p.464981
Behandlung einer Drogenabhängigkeit in Zentralasien und Umsetzung der WHO/UNODC International Standards of Treatment of Drug Use Disorders, Deutscher Suchtkongress 2017, 2017. ,
30-Year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California, Drug and Alcohol Dependence, vol.118, issue.2-3, pp.251-258, 2011. ,
Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study, The Journal of Pain, vol.14, issue.10, pp.1227-1241, 2013. ,
, , 2006.
,
, Single Dose Ketanserin is Little Different from Placebo, InPharma, vol.551, issue.1, pp.16-16, 1986.
, Treatment-Emergent Adverse Event, 2020.
, Serious Adverse Event (SAE), 2014.